Skip to content
stoqly

Pro Dex Inc

PDEX Nasdaq Surgical & Medical Instruments & Apparatus Financials FY2017–FY2026

Last close · Oct 23, 2026

$62.22

0.3%
Compare
Revenue Total sales reported in the income statement.
$77.5M
16.5% vs prior year
Operating margin Operating income as a share of revenue.
16.8%
0.7 pts
Net income Profit after all expenses, interest and tax.
$13.7M
52.2%
Free cash flow Cash from operations minus capital spending.
$6.8M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
17.7%
0.1 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$206M
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
15.1x
On $4.12 EPS (TTM)

What Pro Dex Inc does

No business description yet.

Legal name
PRO DEX INC
Fiscal year ends
June 30, 2026
Latest annual report
10-K · Sep 3, 2026
Accession · CIK
0001079973-26-001215
0000788920

Revenue and margins

Pro Dex Inc had $77.5M of revenue in fiscal 2026, up 16.5% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2017 to 2026, diluted EPS grew 14.2% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $6.8M in fiscal 2026, 8.7% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Pro Dex Inc returned $3.4M to shareholders in fiscal 2026, 50% of free cash flow. The diluted share count fell 1.3%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Pro Dex Inc can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY22FY23FY24FY25FY26
Cash and short-term investments $1.6M$4.1M$6.8M$7.2M$9.3M
Debt incl. finance leases $13.6M$12.8M$12.0M$15.4M$17.5M
Net debt / EBITDA 2.0x1.3x0.6x0.7x0.6x
Debt / equity 0.5x0.4x0.4x0.4x0.4x
Interest coverage 11.0x10.8x12.9x12.9x16.0x
Current ratio 2.7x3.2x2.8x3.2x4.1x
Quick ratio 1.6x1.5x1.7x1.7x2.4x
Total assets $49.1M$51.8M$52.5M$61.2M$74.5M
Total liabilities $23.7M$20.2M$21.6M$24.6M$26.9M
Shareholders' equity $25.4M$31.6M$30.9M$36.6M$47.6M
Net debt (− = net cash) $12.0M$8.7M$5.1M$8.3M$8.2M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Net income is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓ ✓ ✕ ✕ ✓ ✓ ✕ ✓
Return on assets rose — ✕ ✓ ✓ ✕ ✕ ✓ ✕ ✓ ✓
Cash from operations exceeds net income ✕ ✓ ✕ ✕ ✕ ✕ ✕ ✓ ✕ ✕
Debt fell relative to assets — ✓ ✕ ✓ ✕ ✓ ✓ ✓ ✕ ✓
Current ratio rose — ✓ ✕ ✕ ✕ ✕ ✓ ✕ ✓ ✓
Share count didn't rise — ✕ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Gross margin rose — ✓ ✓ ✓ ✕ ✕ ✕ ✕ ✓ ✓
Revenue rose relative to assets — ✕ ✕ ✓ ✕ ✕ ✓ ✓ ✓ ✕
F-score — / 36 / 95 / 97 / 92 / 93 / 97 / 96 / 96 / 97 / 9
Accruals ratio 11.3%−8.1%3.6%4.1%23.1%12.1%3.2%−7.9%18.8%9.5%
Altman Z'' 9.6711.837.907.695.885.666.647.068.168.66

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Income statement
Revenue $21.9M $22.5M $27.2M $34.8M $38.0M $42.0M $46.1M $53.8M $66.6M $77.5M
Gross profit $7.2M $7.9M $9.8M $13.1M $13.6M $13.1M $12.7M $14.6M $19.5M $24.3M
Research and development $1.2M $1.9M $1.9M $2.3M $4.4M $3.0M $2.8M $3.2M $3.6M $3.3M
Operating income $2.7M $2.4M $5.0M $7.1M $4.5M $5.1M $5.8M $7.2M $10.7M $13.0M
Interest expense $0.0M $0.0M $0.2M $0.2M $0.4M $0.5M $0.5M $0.6M $0.8M $0.8M
Pretax income $2.8M $2.6M $5.4M $7.9M $7.6M $5.7M $9.4M $2.6M $12.1M $18.0M
Income tax −$2.1M $1.0M $1.3M $1.8M $1.4M $1.1M $2.4M $0.5M $3.1M $4.4M
Net income $5.1M $1.6M $4.1M $6.1M $6.2M $4.6M $7.1M $2.1M $9.0M $13.7M
Diluted EPS $1.25 $0.37 $0.97 $1.50 $1.57 $1.21 $1.95 $0.60 $2.67 $4.12
Diluted shares 0.00B 0.00B 0.00B 0.00B 0.00B 0.00B 0.00B 0.00B 0.00B 0.00B
Cash flow
Cash from operations $3.2M $3.1M $3.3M $4.9M −$2.1M −$0.8M $5.5M $6.2M −$1.7M $7.2M
Capital expenditure $0.6M $0.9M $1.4M $0.5M $1.8M $1.6M — — $1.2M $0.5M
Free cash flow $2.6M $2.2M $1.9M $4.4M −$3.8M −$2.5M — — −$2.9M $6.8M
Depreciation and amortization $0.6M $0.6M $0.4M $0.6M $0.7M $0.7M $0.9M $1.2M $1.2M $1.4M
Stock-based compensation $0.0M $0.2M $0.0M $0.3M $0.9M $1.3M $0.8M $0.6M $0.6M $0.7M
Acquisitions — — — — — — — — — $6.5M
Share buybacks $0.3M $0.2M $4.0M $3.4M $5.5M $1.6M $1.5M $3.5M $3.5M $3.4M
Dividends and buybacks $0.3M $0.2M $4.0M $3.4M $5.5M $1.6M $1.5M $3.5M $3.5M $3.4M
Balance sheet
Cash and short-term investments $4.9M $7.4M $9.5M $9.0M $5.0M $1.6M $4.1M $6.8M $7.2M $9.3M
Total debt $0.1M $0.0M $4.6M $4.0M $12.8M $13.6M $12.8M $12.0M $15.4M $17.5M
Current assets $12.3M $16.2M $20.8M $22.7M $25.0M $31.2M $31.0M $36.6M $47.3M $53.2M
Current liabilities $2.6M $2.4M $4.3M $5.2M $6.3M $11.4M $9.7M $12.9M $14.6M $13.0M
Inventory $3.1M $4.4M $6.2M $8.2M $8.4M $12.7M $16.2M $15.3M $22.2M $21.5M
Property and equipment, net $1.4M $1.8M $2.7M $2.7M $3.8M $4.8M $5.1M $5.0M $5.2M $5.4M
Goodwill $0.1M — — — — — — — — $6.5M
Intangible assets $0.1M $0.1M $0.1M $0.2M $0.2M $0.1M $0.1M $0.1M $0.0M $0.7M
Total assets $16.4M $19.9M $25.5M $31.1M $40.3M $49.1M $51.8M $52.5M $61.2M $74.5M
Total liabilities $2.6M $2.6M $8.5M $12.1M $20.2M $23.7M $20.2M $21.6M $24.6M $26.9M
Shareholders' equity $13.7M $17.3M $17.0M $19.1M $21.1M $25.4M $31.6M $30.9M $36.6M $47.6M
Margins
Gross margin 32.7% 35.4% 36.0% 37.7% 35.7% 31.2% 27.7% 27.0% 29.3% 31.4%
Operating margin 12.5% 10.6% 18.4% 20.3% 11.9% 12.2% 12.5% 13.3% 16.1% 16.8%
EBITDA margin 15.0% 13.1% 20.0% 21.9% 13.7% 13.9% 14.4% 15.5% 17.9% 18.5%
Net margin 23.2% 7.2% 15.3% 17.5% 16.2% 10.9% 15.3% 4.0% 13.5% 17.6%
FCF margin 12.0% 9.7% 7.1% 12.7% −10.1% −5.9% — — −4.4% 8.7%
Returns
Return on capital 30.7% 15.7% 31.3% 38.9% 12.7% 11.0% 10.7% 16.1% 17.7% 17.7%
Return on capital employed 19.9% 13.7% 23.5% 27.3% 13.3% 13.6% 13.7% 18.1% 23.0% 21.1%
Return on equity 37.1% 10.5% 24.2% 33.9% 30.7% 19.6% 24.8% 6.8% 26.6% 32.4%
Return on assets 31.1% 8.9% 18.3% 21.6% 17.3% 10.2% 14.0% 4.1% 15.8% 20.1%
Return on tangible equity 37.8% 9.5% 24.6% 32.3% 29.5% 18.1% 22.5% 6.9% 24.5% 33.8%
Growth
Revenue growth — 2.4% 21.0% 28.2% 9.2% 10.5% 9.6% 16.8% 23.7% 16.5%
Net income growth — −68.1% 155.9% 47.3% 0.9% −25.9% 54.7% −69.9% 322.1% 52.2%
EPS growth — −70.4% 162.2% 54.6% 4.7% −22.9% 61.2% −69.2% 345.0% 54.3%
FCF growth — −17.3% −10.8% 128.3% −186.9% — — — — —
Share count change — 6.6% −1.1% −5.1% −3.5% −4.4% −3.4% −1.8% −5.9% −1.3%
Financial health
Net debt / EBITDA −1.5x −2.5x −0.9x −0.7x 1.5x 2.0x 1.3x 0.6x 0.7x 0.6x
Debt / equity 0.0x 0.0x 0.3x 0.2x 0.6x 0.5x 0.4x 0.4x 0.4x 0.4x
Interest coverage 228.1x 341.7x 22.7x 29.9x 12.9x 11.0x 10.8x 12.9x 12.9x 16.0x
Current ratio 4.8x 6.7x 4.9x 4.3x 4.0x 2.7x 3.2x 2.8x 3.2x 4.1x
Quick ratio 3.6x 4.9x 3.4x 2.8x 2.6x 1.6x 1.5x 1.7x 1.7x 2.4x
Capital allocation
Capex / revenue 2.8% 4.1% 5.1% 1.5% 4.7% 3.9% — — 1.9% 0.6%
Stock comp / revenue 0.0% 0.9% 0.1% 0.8% 2.4% 3.0% 1.7% 1.1% 0.8% 0.9%
Payouts / FCF 11.9% 10.1% 205.5% 76.5% — — — — — 50.4%
Quality scores
Piotroski F-score — 6.0 5.0 7.0 2.0 3.0 7.0 6.0 6.0 7.0
Altman Z'' 9.7 11.8 7.9 7.7 5.9 5.7 6.6 7.1 8.2 8.7
Accruals ratio 11.3% −8.1% 3.6% 4.1% 23.1% 12.1% 3.2% −7.9% 18.8% 9.5%

Source: SEC EDGAR XBRL filings (CIK 0000788920). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open